These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 28458350)

  • 1. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation.
    Li H; Ying H; Hu A; Hu Y; Li D
    Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
    Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
    Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
    Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
    Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
    J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ
    World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering, hepatoprotective, and atheroprotective effects of the mixture Hong-Qu and gypenosides in hyperlipidemia with NAFLD rats.
    Gou SH; Huang HF; Chen XY; Liu J; He M; Ma YY; Zhao XN; Zhang Y; Ni JM
    J Chin Med Assoc; 2016 Mar; 79(3):111-21. PubMed ID: 26842974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes.
    Veeramani C; Alsaif MA; Al-Numair KS
    Biomed Pharmacother; 2017 Dec; 96():1349-1357. PubMed ID: 29174039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
    Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
    Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
    Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats.
    Zou B; Ge ZZ; Zhang Y; Du J; Xu Z; Li CM
    Food Funct; 2014 Jul; 5(7):1536-46. PubMed ID: 24841999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of granulocyte-colony stimulating factor on non-alcoholic hepatic steatosis in the rat.
    Song YS; Fang CH; So BI; Park JY; Jun DW; Kim KS
    Ann Hepatol; 2013; 12(1):115-22. PubMed ID: 23293202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
    de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
    PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c.
    Zhang J; Tan Y; Yao F; Zhang Q
    Mol Med Rep; 2012 Oct; 6(4):815-20. PubMed ID: 22858825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
    Liu H; Zhong H; Yin Y; Jiang Z
    Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
    Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
    Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.